Navigation Links
Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
Date:10/1/2008

20 percent at the three-month readout to 10 percent because one patient developed a cataract and one patient developed an epiretinal membrane involving the macula prior to the readout. The development of cataracts and epiretinal membranes in a diabetic population are not unusual and are commonly addressed with surgical intervention.

In addition, the six-month readout showed 25 percent of the low dose patients and 41 percent of the high dose patients had an improvement in BCVA of 10 letters or greater from baseline. This is an improvement from the three-month data where 20 percent of low dose patients and 29 percent of high dose patients had gained more than 10 letters compared to baseline.

"It is very encouraging that the number of patients with greater than 10-letter improvement has increased for both doses when comparing the six- month data to the three-month data," said Ken Green, Ph.D., chief scientific officer of Alimera.

From a safety perspective, no adverse events related to intraocular, or inner eye, pressure were seen in the low dose patients, while 12 percent of the high dose patients experienced intraocular pressure increases of 30 mmHg or greater at some time point. Further, 10 percent of the low dose patients and 12 percent of the high dose patients reported an adverse event related to cataract formation, and one additional patient in each dose group underwent a cataract extraction.

"The six-month readout from the Iluvien PK study continues to support the premise that corticosteroids, delivered in low doses in a consistent and sustained manner directly into posterior segment of the eye, can be an efficacious treatment for DME," said Dan Myers, president and CEO of Alimera Sciences, "We are also pleased with Iluvien's safety profile as evidenced by the low IOP rates and the lack of filtration procedures at the month 6 time point."

Data from the PK Study will continue to be evaluated with interim looks at months 12, 18,
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DSMB Again Supports Continuation of Alimera Sciences Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME
2. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
3. BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test
4. Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
5. MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
8. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
9. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
10. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
11. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Insulet Corporation (NASDAQ: PODD ), the ... ® Insulin Management System, today announced preliminary revenue ... The Company also announced that it will postpone the ... conference call from Thursday, July 30, as originally scheduled. ... , Preliminary second quarter revenue ...
(Date:7/29/2015)... 2015  UBM Canon brings MEDevice San Diego Conference ... Marina on September 1-2, 2015, with a multi-track conference ... the Business Development track will be a panel on ... Investors, featuring Renee Ryan , Vice President of ... Ahrens , Partner, Canaan Partners; and Jordan Kramer ...
(Date:7/29/2015)... 2015  According to data released today by the ... monthly Medicare Part D premium is expected to remain ... originally projected, the Pharmaceutical Care Management Association (PCMA) said. ... be a bright spot in American health care. By ... and using cutting edge, cost-saving tools like pharmacy networks ...
Breaking Medicine Technology:Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5MEDevice San Diego Offers Tips on Securing Financial Backing from Investors 2
(Date:7/30/2015)... ... July 30, 2015 , ... Gummy smile surgeon, Dr. Alex Farnoosh, ... surgery, as well as the patented gum depigmentation treatmet. Dr. Farnoosh is a renowned ... many patients from around the world. , “Like treatment of any other disease or ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... Mount Sinai Earns National Cancer Institute Designation , The Tisch Cancer Institute (TCI) ... National Cancer Institute (NCI)-designated cancer center. TCI joins an elite group of 69 ...
(Date:7/30/2015)... ... ... Bird B Gone, the leader in bird control products for commercial, industrial and ... from the AC units and ventilation systems on hospital roofs. Bird droppings can carry ... virus. When these droppings dry, the fine powder can be carried into hospitals via ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... at multinational organizations and NGO’s, according to a new survey by leading international ... that property damage and employee medical expenses represented the largest sources of financial ...
(Date:7/30/2015)... ... 30, 2015 , ... After a three year trial designed to study the ... as the “bionic eye,” researchers have determined the trial to be a success, and ... or already affected by complete vision loss as a result of Retinitis pigmentosa. The ...
Breaking Medicine News(10 mins):Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 3Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2
... (April 19, 2010) -- The University of South Florida (USF) ... health records, with the support of a $5.9 million ... last week. "The University of South Florida is the ... and now is one of just a handful of universities ...
... ... the MTA,s zero-tolerance policy on the usage of cell phones despite this driver,s violent disagreement ... New ... being told by a supervisor that he should not talk on the phone while driving. ...
... at the University of Alabama at Birmingham (UAB) Department ... that will help predict which patients are more likely ... The findings also shed light on the genetics that ... with Caucasians, the researchers said. In data presented ...
... activity in the brain can affect language development in ... more frequently on children with severe language impairment to ... reveals a thesis from the Sahlgrenska Academy at the ... children of varying ages, divided into groups. The first ...
... smoke-free settings, but doctors have concerns, , MONDAY, April ... Reynolds launched Camel Orbs, dissolvable nicotine pellets flavored with ... smokers who find themselves in smoke-free surroundings. , But ... Pediatrics warn that the product, which can ...
... at the University of Alabama at Birmingham (UAB) Department ... that will help predict which patients are more likely ... The findings also shed light on the genetics that ... with Caucasians, the researchers said. In data presented ...
Cached Medicine News:Health News:PaperFree Florida to help move physicians towards electronic health records 2Health News:PaperFree Florida to help move physicians towards electronic health records 3Health News:David Perecman Comments On Bus Driver Assaulting Supervisor In New York 2Health News:UAB researchers find 4 biomarkers important in colorectal cancer treatment prognosis 2Health News:Language dysfunction in children may be due to epileptic brain activity 2Health News:Kids Could Overdose From Nicotine-Laced 'Candy' 2Health News:UAB researchers find 4 biomarkers important in colerectal cancer treatment prognosis 2
... of any biological activity but appears to ... of insulin. Although insulin and C-Peptide are ... fasting levels of C-Peptide are 5-10 fold ... the longer half-life of C-Peptide. The glucagon ...
... The Array Multifocal IOL was designed ... with independence from glasses in most situations. ... IOL is similar to that of a ... usually much better and about 19 in ...
Inquire...
... IgG Enzymelinked Immunosorbent Assays(ELISA) is intended for ... antibody to Measles Rubeola) virus in human ... for the determination of immune status. Paired ... demonstrate seroconversion or a significant rise in ...
Medicine Products: